Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhidan Huayu Capsule is a proprietary Traditional Chinese Medicine (TCM) compound developed by Anhui Anke Biotechnology. It is primarily indicated for the treatment of endometriosis and secondary dysmenorrhea. The formulation is based on the principles of promoting blood circulation and resolving blood stasis, utilizing key ingredients such as *Hirudo* (leech) and *Salvia miltiorrhiza* (Danshen). The active components, including hirudin from the leech and various tanshinones from Salvia, work synergistically to inhibit thrombin activity, reduce inflammatory cytokine levels, and modulate prostaglandin synthesis. This multi-target approach aims to reduce the size of ectopic endometrial lesions, alleviate pelvic pain, and improve menstrual symptoms in patients with gynecological stasis-related disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhidan Huayu Capsule.